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Abstract
Diagnostic tests for veterinary surveillance programs should be efficient, easy to use and,
possibly, economical. In this context, classic Enzyme linked ImmunoSorbent Assay
(ELISA) remains the most common analytical platform employed for serological analyses.
The analysis of pooled samples instead of individual ones is a common procedure that per-
mits to certify, with one single test, entire herds as “disease-free”. However, diagnostic tests
for pooled samples need to be particularly sensitive, especially when the levels of disease
markers are low, as in the case of anti-BoHV1 antibodies in milk as markers of Infectious
Bovine Rhinotracheitis (IBR) disease. The avidin-nucleic-acid-nanoassembly (ANANAS) is
a novel kind of signal amplification platform for immunodiagnostics based on colloidal poly-
avidin nanoparticles that, using model analytes, was shown to strongly increase ELISA test
performance as compared to monomeric avidin. Here, for the first time, we applied the ANA-
NAS reagent integration in a real diagnostic context. The monoclonal 1G10 anti-bovine
IgG1 antibody was biotinylated and integrated with the ANANAS reagents for indirect IBR
diagnosis from pooled milk mimicking tank samples from herds with IBR prevalence
between 1 to 8%. The sensitivity and specificity of the ANANAS integrated method was
compared to that of a classic test based on the same 1G10 antibody directly linked to horse-
radish peroxidase, and a commercial IDEXX kit recently introduced in the market. ANANAS
integration increased by 5-fold the sensitivity of the 1G10 mAb-based conventional ELISA
without loosing specificity. When compared to the commercial kit, the 1G10-ANANAS inte-
grated method was capable to detect the presence of anti-BHV1 antibodies from bulk milk
of gE antibody positive animals with 2-fold higher sensitivity and similar specificity. The
results demonstrate the potentials of this new amplification technology, which permits
improving current classic ELISA sensitivity limits without the need for new hardware
investments.
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Introduction
In the context of animal health control and disease prevention it is fundamental to have access
to efficient diagnostic tests capable of detecting early disease outbreaks and/or guaranteeing the
absence of disease within large territorial extensions. Due to the large number of analyses that
need to be routinely done within surveillance programs, such tests should be efficient, easy to
use and, possibly, economical. Within serology analyses, high versatility and relatively low cost
still make traditional microplate-based Enzyme Linked Immuno Sorbent Assay (ELISA)
remaining the platform most widely used. However, in some cases, too low analyte levels make
classic ELISA tests fail to meet the necessary performance needs, and higher sensitivity meth-
ods are necessary. For example, low antibody titers are common in some relevant veterinary
diseases (e.g. during the prolonged phase of seroconversion to bovine paratuberculosis), or in
pooled sample (sera or milk). With respect to this, bovine bulk milk is a typical example of a
pooled sample widely used in veterinary diagnostics. Its collection is very cheap and easy, help-
ing to reduce surveillance program costs by permitting to certify, with one single test only,
entire herds as “disease-free”.
Limitations in the use of tank milk in comparison with the individual analyses on blood
serum are linked to: a) the lower titres of antibodies physiologically present in the individual
milk compared to the blood serum of the same animal; b) the dilution factor due to sample
pooling in the bulk milk; c) fluctuations of the milk production during the lactation, which can
decrease/increase the milk dilution ratio. Still, many ELISA tests developed for serum analysis
can be extended to individual milk samples without significant loss in specificity or sensitivity.
However, at herd level, extension to bulk milk is sometimes difficult to achieve [1–4]. As a gen-
eral rule, the test must be sensitive enough to detect a single positive reaction in the pool. Cur-
rently, in the European Union—based on the requirements of the directive no. 1964/432/EEC-
commercial ELISA reactions for Brucella and Enzootic Bovine Leukosis antibodies have been
licensed by the National Reference Laboratories for the analysis of bulk milk of 100–200 cows.
In the case of IBR, according to decision n. 2004/558/EC, to date the largest bulk pool size of
the licensed kits corresponds to 50 cows.
The possibility to extend current bulk size limitations will depend only on the availability of
more sensitive analytical tools. Indeed, in recent years, several new technological platforms for
immunodiagnostic tests have been introduced, in general providing faster or more sensitive
solutions than classic ELISA. However, most of these platforms require relatively large invest-
ments in instrumentation and/or sophisticated consumables, with an increase in costs that is
not always sustainable in the veterinary and food control system.
An economically sustainable way to overcome sensitivity limitations in classic ELISA for-
mats is to integrate signal amplifying reagents in the analytical process. For example, this is the
case of the polymerized enzyme horseradish peroxidase (poly-HRPs) reagents, which in some
cases are used as substitutes of the classic monomeric enzyme. A more recent ‘polymer’ based
platform for signal enhancement is the one based on the Avidin-Nucleic-Acid-NanoASsem-
blies (ANANAS), a kind of poly-avidin nanoparticles, that can be used as alternative to mono-
meric avidin in several diagnostic applications [5–9]. The ANANAS nanoparticles (120 nm in
diameter) are characterized by high stoichiometric control and contain about 350 functional
assembled avidins. When used in combination with analyte-specific biotinylated antibodies
and a biotinylated signal generating moiety, they bring to the immobilized analyte higher signal
than monomeric avidin so that a strong signal amplification is generated (Fig 1). Compared to
poly-HRPs, the ANANAS technology is more versatile as the reagents can be integrated with
many signal generating technologies, including fluorescence, chemiluminescence or enzyme-
generated colour [6,10,11].
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In this work the ANANAS technology was integrated in an in-house trapping-indirect
ELISA, originally developed for indirect diagnosis of Infectious Bovine Rhinotracheitis (IBR)
through the detection of whole-virus antibodies in individual bovine blood sera (Fig 1). For
this purpose, the anti-bovine IgG1 monoclonal antibody (1G10), classically employed as HRP
conjugate in the conventional ELISA, was biotinylated and integrated with the ANANAS/bio-
tin-HRP based detection reagents (Fig 1). Both detection methods were tested for their ability
to diagnose IBR from milk samples. Sensitivity and specificity parameters were evaluated using
reconstructed samples mimicking tank milk of different IBR prevalence (8-4-2 and 1%). For
comparative purposes we included in our investigation a third kit, namely the commercial IBR
Pool Ab Test from Idexx, recently introduced in the market, validated for both milk and serum
testing.
IBR was selected for this study because a) it is a relevant disease, for which, currently, con-
trol programmes- based on bulk milk analysis- are ongoing in many countries; b) the reduced
pool size (to date max 50 cows) of bulk milk samples which can be analyzed with the commer-
cial ELISA kits currently available undermines the employment of the test in medium—large
sized (>50 lactating cows) dairy farms.
IBR is an infectious disease caused by a bovine Herpesvirus (BoHV-1), which can be asymp-
tomatic or cause mild to severe clinical signs [12–17]. The disease causes major economical
losses in livestock production and reduces milk production, while the virus can be shed in
semen and can be transmitted during natural and artificial insemination, propagating its effects
onto next generations. For these reasons, control and eradication programs are actively being
carried out in many regions in Europe [18,19], including North Eastern Italy, according to the
legal provisions laid down in the 2004/558/EC decision.
While the reference BoHV-1 diagnostic method is the virus neutralization (VN) test [20],
diagnosis through the detection of anti-BoHV-1 antibodies by ELISA (in serum or milk)
Fig 1. Cartoon (not in scale) depicting the two 1G10mAb-based ELISAs for detection of anti BoHV-1
antibodies: classic configuration using the antibody-HRP conjugate (left) and ANANAS integrated
method (right). For simplicity reasons, the mAb used for Bo-HV1 adsorption on the plate (see methods) is
not included in the scheme.
doi:10.1371/journal.pone.0145912.g001
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[21,22] is less time consuming and more convenient to perform within large scale screenings
[23]. Commercial competitive and non competitive ELISA kits validated for anti-BoHV-1 anti-
body detection in sera (individual or pool) or milk (individual or bulk) have been available for
some years now. However, IBR bulk tests suffer from low sensitivity problems when using clas-
sic ELISA tools and amplification strategies are adopted, for example by concentrating the anti-
bodies in the sample prior to analysis [24] (e.g. cattletypeMilk Prep Kit by Qiagen and
Eradikit1 IgG Milk Purification Kit by IN3 Diagnostic). In other cases, an amplification strat-
egy has been inserted within the ELISA detecting reagents (IDEXX BHV-1 Bulk Milk Ab Test),
leading to a high sensitive method. However, in this case, a “sensitive” washing step is required
before signal development to prevent false positive readings. In addition, this test recommends
the use of different cut-off values for data elaboration depending on the sample pool size, and
this is difficult to perform in routine analyses as it requires tracking the size of each pool in the
collection phase, dedicated software and/or qualified personnel for rough data elaboration. As
of today, the issue of sensitivity in IBR diagnosis from bulk milk is not fully solved, justifying
for the search for novel amplification solutions.
Materials and Methods
Reagents
BoHV-1 antigen. An historical respiratory strain of BoHV-1, isolated during ‘70s in Bre-
scia province from a caw affected by IBR, was used as antigen in ELISA. Briefly, the virus was
propagated in Aubek cell monolayers and harvested when cytopathic effect was maximum (24
h post-infection). The tissue culture harvest was centrifuged at 3000 g for 20 min and then
inactivated with 0.001M Binary Ethyleneimine (BEI) for 48 h at 26°C; residual BEI was neutral-
ized by sodium-thiosulphate at a final concentration of 2%.
The anti-bovine IgG1monoclonal antibody (mAb) 1G10 was developed at IZSLER. The
1G10-HRP conjugate was obtained through classic bioconjugation protocols. For integration
in the ANANAS platform, mAb 1G10 was biotinylated through conventional conjugation pro-
tocols using a biotin N-hydroxysuccinimide derivative with a long (5KDa) poly(ethylene gly-
col) (PEG) spacer arm (Laysan Bio, AL, USA). ANANAS nanoparticles, biotin-HRP and
ANANAS dilution buffer (DB) were kindly provided by ANANAS Nanotech (Padova, Italy,
code# BioDe).
Milk and blood sera samples
Milk (individual and bulk) and blood sera samples were already available as part of routine col-
lection and analysis programs carried out for animal health surveillance and food testing activi-
ties at regional level. No specific permission was required for sample collection, since sampling
actions took place for compulsory routinely controls (quality assessment of milk) or on the ini-
tiative of the trusted veterinarian (blood) for measuring the IBR immune coverage as well as
virus circulation in vaccinated dairy herds. Blood samples were collected through caudal vein
bleeding, according to the common veterinary practice. No animal was sacrificed.
a. BoHV1 individual positive milk samples were originating from cows (no. = 136) posi-
tive for IBR total antibodies in blood (ELISA test—SVANOVIR1 IBR Ab); according to the
result for IBR-gE antibodies in blood (ELISA test—Idexx IBR gE Ab), positive cows were classi-
fied as either infected (no. = 66, IBR gE-antibody positive) or vaccinated (no. = 70, IBR gE-anti-
body negative); all infected cows were present in a farm when, 22 months before collecting the
samples used for the present study, an IBR outbreak was diagnosed by means of PCR on nasal
swabs; vaccinated cows were kept in a second farm, which was consistently negative for IBR gE
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antibodies over time. All cows—both infected and vaccinated—received a booster immuniza-
tion with gE antibody-deleted marker vaccine every 6 months.
b. Bulk BHV1- negative milk samples were tank samples obtained from farms in the Bol-
zano province (Italy) which is free from IBR in accordance to Article 10 of Dir no. 1964/432/
EEC, and whose cattle population is negative for IBR total antibodies. The average farm size in
this province is small, with 5–10 lactating animals/herd.
c. Negative diluting milk solution was prepared by pooling negative tank samples of the
Bolzano province.
After collection, all samples were added of sodium azide (NaN3) (final concentration 0.08
mg/mL). Individual negative and diluting milk solutions were stored at 4°C and used within 4
weeks from sampling. Positive samples were maintained at -20°C, thawed the day of testing,
and serially diluted from 1:12.5 to 1:100 with negative diluting milk solution before analysis,
thus simulating herd prevalence from 8% to 1%.
Negative controls were obtained from blood serum of a seronegative cow, diluted 1:50
(classic method with 1G10-HRP) or 1:5000 (ANANAS integrated method) in 1% yeast extract
solution. Positive controls were dilutions of the serum from a seropositive animal, namely
1:50 or 1:800 in 1% yeast extract for the classic or the ANANAS-integrated methods respec-
tively, pre-selected in order to yield, after 20 minutes of color development, 450 nm readouts of
about 1.0 OD.
ELISA procedures
a. Idexx IBR Pool Ab Test, Part Number: 99–55511 was used according to the manufacturer
instructions.
b. Classic and ANANAS integrated methods
The test is a trapping-indirect ELISA in which the BoHV1 antigen is trapped onto the solid
phase by an anti-BoHV1 mAb (mAb 4E5 developed at IZSLER). 96-well microplates (NUNC
Maxisorp) were coated by overnight incubation at 4°C with an optimal concentration of the
partially purified trapping mAb in carbonate/bicarbonate buffer, pH 9.6. After three washings
with PBS containing 0.05% Tween 20 (PBST), the unpurified BoHV1 antigen was then dis-
pensed in even columns (Ag+) at a predetermined saturating dilution in ELISA buffer (PBS pH
7.4, containing 1% yeast extract and 0.05% Tween 20—this buffer permits concurrent antigen
immobilization and surface blocking). Odd columns received ELISA buffer alone(Ag-). The
plates were then incubated for 1h at 37°C and washed again. These sensitized immunoplates
were used immediately or were alternatively treated with a stabilizing solution, dried, sealed
and stored at 4°C maintaining reactivity for over one year.
For the analysis, milk samples were incubated with the Ag+/Ag- well pair, (45 min, 37°C)
under gentle shaking, in parallel with positive and negative controls delivered in each plate.
After washing with PBST, the presence of antibodies bound to the BoHV1 antigen was detected
using: the anti-bovine IgG1 mAb 1G10, as HRP conjugate diluted in ELISA buffer (60 min,
room temperature, RT) in the classic method; the same mAb 1G10 as biotin conjugate, diluted
in DB (30 min, RT), followed (after washing with PBST) by the addition of ANANAS nanopar-
ticles (60 min, RT) and (after washing again with PBST) biotin-HRP (30 min, RT) in the ANA-
NAS integrated method. Nanoparticles and biotin-HRP (Fig 1) were used according to the
manufacturer instructions.
After a final washings cycle with PBST, color development was obtained by distribution of a
reday-to-use tetramethylbenzidine (TMB) solution (KPL, USA). Along the method optimiza-
tion experiments, the reaction was blocked (0.5 M H2SO4) after 10 minutes. In all other experi-
ments, color development was blocked when the signal at 620 nm of Ag+ well of the positive
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controls reached a value of about 0.4 OD (maximum 20 min) (corresponding to about 1.0 at
450 nm). Final plate reading was carried out at 450 nm. Standard volumes of 50 μL/well were
used in each step of the reactions. Washing steps were carried out with Wellwash 4MK 2
microplate washer (ThermoFisherScientific, Waltham, MA, USA). Plate readouts were
obtained with the Multiskan FC microplate reader (ThermoFisherScientific).
For result analysis, delta absorbance values (net OD) were calculated by subtracting the
absorbance readings on Ag- wells from those of the corresponding Ag+ wells.
Reagent optimization
To find out the best concentration of the biotinylated 1G10 antibody to be used in the ANA-
NAS integrated assay, two positive samples of different titer were generated using the milk of a
positive cow diluted to different extent (1:10 and 1: 100) in negative diluting milk. Data analysis
was based on the analysis of the net OD and the absorbance registered at Ag- well (OD Ag-).
Sensitivity Comparison Pilot study
Two small sets of positive samples from “vaccinated” (N = 8) or “infected” (N = 10) animals
were analyzed upon dilution to different extent (1:25 and 1:50) in negative diluting milk solu-
tion and tested with both the ANANAS integrated and classic tests.
Large Scale Validation
A large set of negative tank (N = 252) or positive individual (N = 136) samples—from vacci-
nated (N = 70) and infected (N = 66) animals—was used for the large validation experiment.
Negative samples were tested as such, while positive samples were serially diluted in negative
diluting milk solution (from 1:12.5 to 1:100) to mimic different values of seroprevalence in the
group of lactating cows, (8, 4, 2, 1%) or different antibody levels, as expected in the field con-
text. For data analysis, the absorbance readings were mathematically transformed into S/P val-
ues [1] according to: S/P = (net ODsample / net ODpositive control).
The non-parametric ROC curve was used to assess the diagnostic performance of the differ-
ent serological kits and to define the cut-off values for data elaboration. The same set of sam-
ples was also analysed with a commercial ELISA kit (IBR Pool Ab Test) from Idexx
Laboratories, Inc.; S/P values were calculated according to the manufacturer’s instructions
[(ODsample—ODneg control) / (ODpos control−ODneg control)]; in addition to the manufacturer’s
cut-off value (S/P> 0.25), results were evaluated using also the same cut-off value set for the
home-made classic and ANANAS amplified ELISAs.
Results and Discussion
1. ANANAS Integrated Reagent Optimization
The concentration of the detector biotinylated mAb 1G10 in the ANANAS-integrated test had
to be optimized so to maximize positive signal and minimize noise-related background. Fig 2
displays the net OD and OD Ag- values obtained in the analysis of negative milk and a positive
sample diluted in negative milk, as a function of biotinylated 1G10 concentration in the assay.
The net OD value of the negative sample remained below 0.1 OD at all biotin-1G10 dilutions
tested (between 0.1 and 3 μg/mL), while the net OD value of the positive samples was strongly
correlated with the antibody concentration. This indicates that the net OD signal generated by
the positive samples is specific. The plot of the net OD of the positive samples vs antibody con-
centration did not reach a plateau, indicating that the net signal could be further increased by
using higher biotin antibody concentrations. However, also the signal generated on the Ag-
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wells increased with the antibody concentration. The occurrence of this signal, which is proba-
bly related to non-specific interactions between 1G10 and some of the components used in
plate conditioning, does not permit to increase indiscriminately the concentration of the anti-
body without generating a noisy plate. This non-specific signal—which could not be reduced
even using extensive washing steps or by changing the plate blocking media- is disturbing,
especially when testing low titer samples (e.g. the 1:100 dilution). Based on these experiments a
concentration of 2 μg/mL was selected for all further experiments.
2. Sensitivity Comparison Pilot study
A second preliminary investigation was carried out to quantify the amplification potential of
the ANANAS integration. As summarized in Fig 3, the net OD generated by using the ANA-
NAS integrated method was about 5-fold higher than that generated by the classic one. Glyco-
protein E-antibody positive animals showed a higher reactivity than gE antibody-negative
ones, likely due to the different origin of their immune response (infection + vaccination vs
vaccination only).
3. Large Scale Validation
Initially, for both classic and ANANAS integrated tests, we calculated the cut-off values which
minimize the distance between the curve and upper left corner of the ROC curves, and the
Diagnostic Sensitivity (DSe), the Diagnostic Specificity (DSp) and the Area Under Curve
(AUC) were calculated using such values. Considering the whole sample population, this anal-
ysis gave (see also S2 Table), for the ANANAS integrated method: Cut-off S/P = 0.04;
Dse = 0.86 –Dsp = 0.90; and for the classic method: Cut-off S/P = 0.02, Dse = 0.81 –Dsp = 0.85.
Notably, these Dsp values are too low for speculating about a routinary use of the tests, because
of the high frequency of false positive results. In fact, a bulk milk test for IBR antibodies is tipi-
cally employed for substantiating the freedom from the disease in a negative population and,
for this reason, a 10–15% of false positive results is not acceptable. Therefore, we recalculated
Fig 2. Optimization of detector mAb (1G10-biotin) concentration. NetOD (grey columns), and ODAg- (black columns) registered in the analysis of
negative diluting milk and an individual positive milk sample diluted 1:10 and 1:100 in negative diluting milk, as obtained with the ANANAS-integrated test
using biotin-1G10 at different concentrations. TMB development was blocked after 10 min reaction. Each sample was analyzed in duplicate. These data are
also reported in table format in (S1 Table).
doi:10.1371/journal.pone.0145912.g002
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specifity and sensitivity values upon setting the cut-off value for positive samples at S/P> 0.1.
This value was selected and used for all further data analyses because a) for both methods, it
represents the mean S/P of negative samples + 3 standard deviations, and b) it is the lowest
value associated with a practically significant net OD (about 0.15–0.20). Using this threshold,
the observed specificity is> 0.995 (Table 1), which is a much more useful value for screening
negative populations. By the way, due to the small size of the dairy farms of the Bolzano prov-
ince, individual milk of false-positive reactors is less diluted, thus increasing the likelihood of
false-positive bulk milk results. In many European areas geared to dairy production the average
farm size is larger and, consequently, specificity values of the test should be higher.
Fig 3. Assay sensitivity comparison in the pilot study.Maximum, minimum and median net OD values registered in the analysis of individual positive milk
samples (no. 8 from gE-negative and no. 10 from gE-positive cows) diluted 1:25, 1:50 in negative diluting milk, using 1G10 in the classic or ANANAS-
integrated configuration.
doi:10.1371/journal.pone.0145912.g003
Table 1. ELISA test specificity comparison. Assay specificity calculated for the classic method based on
1G10-HRP conjugate, the 1G10-ANANAS integrated, and the commercial IDEXX one. Results of the IDEXX
test were interpreted adopting the S/P threshold indicated by the manufacturer (0.25) or the same one
adopted for the 1G10 based methods (0.1). The results have been obtained using 252 negative tank milk
samples from farms in the Bolzano province
TEST Speciﬁcity
ANANAS (S/P threshold >0.10) 99.6%
Classic (S/P threshold >0.10) 99.6%
Idexx (S/P threshold >0.25) 100%
Idexx (S/P threshold >0.10) 100%
doi:10.1371/journal.pone.0145912.t001
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Noteworthy, specificity, which depends mostly on the quality of the antibody-antigen recog-
nition event, was comparable for the two 1G10 mAb-based ones. The fact that the specificity of
1G10-based classic test was maintained upon ANANAS integration indicates that the long
PEG spacer biotinylation necessary for optimal ANANAS nanoparticle integration does not
alter 1G10 antigen recognition.
As to the sensitivity, data were analyzed both collectively and considering separately sample
dilution and gE-antibody positivity/negativity status. Fig 4 displays the relationship between
sample dilution and sensitivity for the three tests, taking into account collected samples or gE-
antibody positive/negative samples separately.
In general, ANANAS integration increased dramatically 1G10 mAb-based test sensitivity.
The difference between classic and ANANAS integrated tests is such that no statistical support
was necessary to demonstrate significance. The ANANAS-integrated method was also signifi-
cantly more sensitive than the commercial kit using the S/P threshold indicated by the manu-
facturer (0.25). When adopting the same S/P threshold (0.1) for the two tests, similar
sensitivity was registered when taking into consideration the full sample population.
Interestingly, when analyzing separately the results on gE-antibody positive/negative animal
samples, the ANANAS integrated method was consistently more sensitive on samples from
gE-antibody positive animals regardless of the dilution factor (see also Supplementary Infor-
mation, S3 Table), in line with what observed along the sensitivity comparison pilot study (Fig
3). On the other hand, the commercial kit showed higher sensitivity for gE-antibody positive
samples at the 1:12.5 and 1:25 dilutions, but at higher dilutions (1:50 and 1:100) the sensitivity
parameter was either independent of the gE-antibody positivity/negativity status or even more
favourable towards the gE-antibody negative samples. Likely, the difference between the two
tests is unrelated to the signal amplification strategy, and we can speculate it may be related to
differences in antigen presentation and/or reactivity of the anti-bovine immunoglobulin detec-
tor. In the plates used with the classic and ANANAS integrated 1G10 mAb based methods,
whole inactivated BoHV-1 were immobilized so to be able to capture all of the IBR related
immunoglobulins present in the sample. The BoHV-1 antigen used in the commercial kit is
not indicated by the manufacturer, so we can only speculate that it is capable of collecting a
smaller subset of IBR related antibodies. It is important to note that along surveillance pro-
grams it is more important to detect gE-antibody positive (infected) animals than gE-antibody
Fig 4. ELISA tests sensitivity comparison. Sensitivity as a function of milk dilution using the (o) classic test, (▲) ANANAS integrated, (□) Commercial with
0.25 S/P threshold, (&) commercial with 0.1 S/P threshold methods. Data have been elaborated taking into consideration all animals (left panel) or
separating the results of anti-gE positive (mid panel)/negative (right panel) animals. The dashed parts of the curves in mid panel were generated by linear
extrapolations from the two closest data points. The vertical dotted lines highlight the interception of dilution curves with the 95/90% sensitivity. These data
are also reported in table format in (S3 Table).
doi:10.1371/journal.pone.0145912.g004
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negative (vaccinated) ones: indeed vaccinated animals testing false negative do not exert any
consequence in terms of epidemiological risk.
Extrapolation of anti-gE-antibody positive sample data indicates that the dilution limits
yielding 95%/90% sensitivity are 1:34/1:44, 1:16/1:21 and 1:4/1:6 for the ANANAS-integrated,
commercial IDEXX with 0.1 S/P threshold, and classic methods, respectively. In other word,
the ANANAS-integrated 1G10 method is two-fold more sensitive than the commercial kit and
between 6–11 fold more sensitive than the original in-house ELISA in identifying IBR related
IgGs from milk of anti-gE-antibody positive (infected) animals.
Conclusions
The results showed that it is feasible to improve a test developed for single serum testing to
pooled milk, by switching from an antibody-HRP conjugate to the ANANAS integrated detec-
tion method. The system is convenient to use and does not require novel instrumentation
investments. In this case, about 5-fold increase in analytical sensitivity was achieved by replac-
ing the antibody conjugate with the ANANAS integrated detection. It is worth noticing that, in
other contexts and using model analytes, ANANAS integration was capable of improving sen-
sitivity more than the value obtained here. Indeed, the efficacy of an amplification system also
depends on the quality of the primary recognition, as amplification involves both signal and
noise. In this case, the ANANAS amplification potential had to be down regulated to avoid the
increase of noise due to non-specific interaction of the detector anti-bovine IgG1 mAb 1G10
with the coated plate. Nevertheless, the method here developed was more sensitive than the
commercial kit in detecting IBR related IgGs from animals that were subject to a disease out-
break during their lifetime, with the capability of detecting 2.5% prevalence with more than
90% sensitivity.
From a more general point of view, the results prove that the ANANAS platform can be
used as a valid alternative to other amplification systems currently adopted to improve ELISA
tests that suffer from sensitivity issues. Further advantage of the ANANAS reagents is that they
can be integrated with signal generating systems others than the peroxidase, such as the alkalin
phosphatase or natural or synthetic fluorophores. This permits to expand its amplification
potential to analytical platforms different than ELISA. Investigation in this direction is part of
ongoing investigations.
Supporting Information
S1 Table. Net OD, and ODAg-Neg registered in the analysis of negative diluting milk and
of individual positive milk diluted in negative diluting milk, as obtained with the ANA-
NAS-integrated test using biotin-1G10 at different concentration.
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S2 Table. Cut-off value, Diagnostic Sensitivity (DSe), Diagnostic Specificity (DSp) and
Area Under Curve (AUC) of the classic and the ANANAS-integrated Elisa methods calcu-
lated with non-parametric ROC curve analysis.
(DOC)
S3 Table. Sensitivity (and 95% confidence intervals) of the three ELISA tests calculated
according to specified thresholds.
(DOC)
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